A Study to Assess Safety, Tolerability, and PK of EDG-5506 in Healthy Volunteers and Becker Muscular Dystrophy Adults
Clinical trial NCT04585464 · COMPLETED
Trial details
- NCT number
- NCT04585464
- Sponsor
- Edgewise Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-12
- Primary completion
- 2021-11-15
- Enrollment
- 127
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.